Endocrinology
Timely detection and diagnosis of hormone-related diseases can significantly improve prognosis. Through our extensive rare disease-centric Bio/Databank, we can provide you with a comprehensive and accurate analysis of genetic variants associated with hormone-related diseases. Our medical reports include treatment recommendations and a differential diagnosis, if applicable – allowing for genetic counseling and informed treatment decisions.
Diabetes and obesity panel
Our diabetes and obesity panel is recommended for patients with abnormalities in glucose metabolism, such as hyperinsulinemic hypoglicemia, diabetes neonatal, MODY, diabetes in adults, and familial hypercholesterolemia, as well as for patients displaying insulin resistance, from mild to the severe spectrum (Donohue syndrome), and for patients with familial hyperinsulinism. Disorders caused by imprinting errors or uniparental disomy, such as 6q24-related transient neonatal diabetes mellitus and Beckwith Wiedemann syndrome, are not detected with this panel.
No. of genes: | 265 |
---|---|
TAT: | 25 business days |
Coverage: | ≥99.00% ≥20x |
Details: |
NGS including CNV analysis
|
Gene | OMIM (Gene) | Associated diseases (OMIM) | Inheritance |
---|---|---|---|
ABCA1 | 600046 | HDL deficiency, familial, 1 | AD |
Tangier disease | AR | ||
ABCC8 | 600509 | Diabetes mellitus, transient neonatal 2 | - |
Diabetes mellitus, noninsulin-dependent | AD | ||
Hyperinsulinemic hypoglycemia, familial, 1 | AD, AR | ||
Hypoglycemia of infancy, leucine-sensitive | AD | ||
Diabetes mellitus, permanent neonatal 3, with or without neurologic features | AD, AR | ||
ABCG5 | 605459 | Sitosterolemia 2 | AR |
ABCG8 | 605460 | Gallbladder disease 4 | - |
Sitosterolemia 1 | AR | ||
ACAT1 | 607809 | Alpha-methylacetoacetic aciduria | AR |
ACSF3 | 614245 | Combined malonic and methylmalonic aciduria | - |
ADCY3 | 600291 | Obesity, susceptibility to, BMIQ19 | AR |
AFF4 | 604417 | CHOPS syndrome | AD |
AGL | 610860 | Glycogen storage disease IIIb | AR |
Glycogen storage disease IIIa | AR | ||
AGRP | 602311 | Obesity, late-onset | AD, AR, MF |
Leanness, inherited | AD, AR, MF | ||
AIP | 605555 | Pituitary adenoma 1, multiple types | AD, SM |
Pituitary adenoma predisposition | AD, SM | ||
AIRE | 607358 | Autoimmune polyendocrinopathy syndrome, type I, with or without reversible metaphyseal dysplasia | AD, AR |
AKT2 | 164731 | Diabetes mellitus, type II | AD |
Hypoinsulinemic hypoglycemia with hemihypertrophy | AD | ||
ALDOA | 103850 | Glycogen storage disease XII | AR |
ALDOB | 612724 | Fructose intolerance, hereditary | AR |
ALG1 | 605907 | Congenital disorder of glycosylation, type Ik | AR |
ALG11 | 613666 | Congenital disorder of glycosylation, type Ip | AR |
ALG12 | 607144 | Congenital disorder of glycosylation, type Ig | AR |
ALG3 | 608750 | Congenital disorder of glycosylation, type Id | AR |
ALG6 | 604566 | Congenital disorder of glycosylation, type Ic | AR |
ALG8 | - | Polycystic liver disease 3 with or without kidney cysts | AD |
Congenital disorder of glycosylation, type Ih | AR | ||
ALG9 | 606941 | Congenital disorder of glycosylation, type Il | AR |
Gillessen-Kaesbach-Nishimura syndrome | AR | ||
ANGPTL3 | 604774 | Hypobetalipoproteinemia, familial, 2 | AR |
APOA1 | 107680 | ApoA-I and apoC-III deficiency, combined | AR |
Hypoalphalipoproteinemia, primary, 2, with or without corneal clouding | AR | ||
Hypoalphalipoproteinemia, primary, 2, intermediate | AD | ||
Amyloidosis, 3 or more types | AD | ||
APOA5 | 606368 | Hyperchylomicronemia, late-onset | AD |
Hypertriglyceridemia, susceptibility to | AD | ||
APOB | 107730 | Hypobetalipoproteinemia | AR |
Hypercholesterolemia, familial, 2 | AD | ||
APOC2 | - | Hyperlipoproteinemia, type Ib | AR |
APOC3 | 107720 | Apolipoprotein C-III deficiency | - |
APOE | 107741 | Sea-blue histiocyte disease | AR |
Lipoprotein glomerulopathy | - | ||
?Alzheimer disease, protection against, due to APOE3-Christchurch | AD | ||
Hyperlipoproteinemia, type III | - | ||
Coronary artery disease, severe, susceptibility to | - | ||
?Macular degeneration, age-related | AD | ||
Alzheimer disease 2 | AD | ||
APPL1 | 604299 | Maturity-onset diabetes of the young, type 14 | AD |
AQP2 | 107777 | Diabetes insipidus, nephrogenic | AD, AR |
ARL13B | 608922 | Joubert syndrome 8 | AR |
ARL6 | 608845 | Retinitis pigmentosa 55 | AR |
Bardet-Biedl syndrome 1, modifier of | AR, DR | ||
Bardet-Biedl syndrome 3 | AR | ||
ARMC5 | 615549 | ACTH-independent macronodular adrenal hyperplasia 2 | AD, SM |
ATP6V0A2 | 611716 | Cutis laxa, autosomal recessive, type IIA | AR |
Wrinkly skin syndrome | AR | ||
AVP | 192340 | Diabetes insipidus, neurohypophyseal | AD |
AVPR2 | - | Nephrogenic syndrome of inappropriate antidiuresis | XLR |
Diabetes insipidus, nephrogenic | XLR | ||
B4GALT1 | 137060 | Congenital disorder of glycosylation, type IId | AR |
BBS1 | 209901 | Bardet-Biedl syndrome 1 | AR, DR |
BBS10 | 610148 | Bardet-Biedl syndrome 10 | AR |
BBS12 | 610683 | Bardet-Biedl syndrome 12 | AR |
BBS2 | 606151 | Bardet-Biedl syndrome 2 | AR |
Retinitis pigmentosa 74 | AR | ||
BBS4 | 600374 | Bardet-Biedl syndrome 4 | AR |
BBS5 | 603650 | Bardet-Biedl syndrome 5 | AR |
BBS7 | 607590 | Bardet-Biedl syndrome 7 | AR |
BBS9 | 607968 | Bardet-Biedl syndrome 9 | AR |
BLK | 191305 | Maturity-onset diabetes of the young, type 11 | AD |
CANT1 | 613165 | Desbuquois dysplasia 1 | AR |
Epiphyseal dysplasia, multiple, 7 | AR | ||
CC2D2A | 612013 | Meckel syndrome 6 | AR |
Retinitis pigmentosa 93 | AR | ||
Joubert syndrome 9 | AR | ||
COACH syndrome 2 | AR | ||
CCDC28B | 610162 | Bardet-Biedl syndrome 1, modifier of | AR, DR |
CEL | 114840 | Maturity-onset diabetes of the young, type VIII | AD |
CEP164 | 614848 | Nephronophthisis 15 | AR |
CEP19 | 615586 | Morbid obesity and spermatogenic failure | AR |
CEP290 | 610142 | Leber congenital amaurosis 10 | - |
Meckel syndrome 4 | AR | ||
?Bardet-Biedl syndrome 14 | AR | ||
Senior-Loken syndrome 6 | AR | ||
Joubert syndrome 5 | AR | ||
CETP | 118470 | Hyperalphalipoproteinemia | AD |
[High density lipoprotein cholesterol level QTL 10] | AD | ||
CFAP418 | 614477 | Retinitis pigmentosa 64 | AR |
Cone-rod dystrophy 16 | AR | ||
Bardet-Biedl syndrome 21 | AR | ||
CHD2 | 602119 | Epileptic encephalopathy, childhood-onset | AD |
CISD2 | 611507 | Wolfram syndrome 2 | AR |
CNOT1 | 604917 | Holoprosencephaly 12, with or without pancreatic agenesis | AD |
Vissers-Bodmer syndrome | AD | ||
COG1 | 606973 | Congenital disorder of glycosylation, type IIg | AR |
COG4 | 606976 | Congenital disorder of glycosylation, type IIj | AR |
Saul-Wilson syndrome | AD | ||
COG5 | 606821 | Congenital disorder of glycosylation, type IIi | AR |
COG6 | 606977 | Shaheen syndrome | AR |
Congenital disorder of glycosylation, type IIl | AR | ||
COG7 | 606978 | Congenital disorder of glycosylation, type IIe | AR |
COG8 | 606979 | Congenital disorder of glycosylation, type IIh | - |
CP | 117700 | Cerebellar ataxia | AR |
Hemosiderosis, systemic, due to aceruloplasminemia | AR | ||
[Hypoceruloplasminemia, hereditary] | AR | ||
CPE | 114855 | Intellectual developmental disorder and hypogonadotropic hypogonadism | AR |
CREBBP | 600140 | Menke-Hennekam syndrome 1 | AD |
Rubinstein-Taybi syndrome 1 | AD | ||
CUL4B | 300304 | Mental retardation, X-linked, syndromic 15 (Cabezas type) | XLR |
CYP27A1 | 606530 | Cerebrotendinous xanthomatosis | AR |
DCAF17 | 612515 | Woodhouse-Sakati syndrome | AR |
DNAJC3 | 601184 | ?Ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus | AR |
DOLK | 610746 | Congenital disorder of glycosylation, type Im | AR |
DPM1 | 603503 | Congenital disorder of glycosylation, type Ie | AR |
DPM2 | 603564 | Congenital disorder of glycosylation, type Iu | AR |
DPM3 | 605951 | Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 15 | AR |
?Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 15 | AR | ||
DYRK1B | 604556 | Abdominal obesity-metabolic syndrome 3 | AD |
EHMT1 | 607001 | Kleefstra syndrome 1 | AD |
EIF2AK3 | 604032 | Wolcott-Rallison syndrome | AR |
EIF2B1 | 606686 | Leukoencephalopathy with vanishing white matter | AR |
EIF2S3 | 300161 | MEHMO syndrome | XLR |
ENO3 | 131370 | ?Glycogen storage disease XIII | AR |
ENPP1 | 173335 | Arterial calcification, generalized, of infancy, 1 | AR |
Obesity, susceptibility to | AD, AR, MF | ||
Hypophosphatemic rickets, autosomal recessive, 2 | AR | ||
Cole disease | AD | ||
Diabetes mellitus, non-insulin-dependent, susceptibility to | AD | ||
EPM2A | 607566 | Epilepsy, progressive myoclonic 2A (Lafora) | AR |
FBP1 | 611570 | Fructose-1, 6-bisphosphatase deficiency | AR |
FOXP3 | 300292 | Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked | XLR |
G6PC1 | 613742 | Glycogen storage disease Ia | AR |
GAA | 606800 | Glycogen storage disease II | AR |
GATA6 | 601656 | Persistent truncus arteriosus | - |
Atrioventricular septal defect 5 | AD | ||
Tetralogy of Fallot | AD | ||
Atrial septal defect 9 | AD | ||
Pancreatic agenesis and congenital heart defects | AD | ||
GBE1 | 607839 | Glycogen storage disease IV | AR |
Polyglucosan body disease, adult form | AR | ||
GCK | 138079 | Diabetes mellitus, permanent neonatal 1 | AR |
Diabetes mellitus, noninsulin-dependent, late onset | AD | ||
Hyperinsulinemic hypoglycemia, familial, 3 | AD | ||
MODY, type II | AD | ||
GCKR | 600842 | [Fasting plasma glucose level QTL 5] | - |
GH1 | 139250 | Growth hormone deficiency, isolated, type IB | - |
Growth hormone deficiency, isolated, type IA | AR | ||
Kowarski syndrome | AR | ||
Growth hormone deficiency, isolated, type II | AD | ||
GHR | 600946 | Hypercholesterolemia, familial, modifier of | AD, AR |
Laron dwarfism | AR | ||
Growth hormone insensitivity, partial | AD | ||
Increased responsiveness to growth hormone | AD | ||
GHRHR | 139191 | Growth hormone deficiency, isolated, type IV | AR |
GHRL | 605353 | Obesity, susceptibility to | AD, AR, MF |
GLI3 | 165240 | Pallister-Hall syndrome | AD |
Polydactyly, preaxial, type IV | AD | ||
Polydactyly, postaxial, types A1 and B | AD | ||
Greig cephalopolysyndactyly syndrome | AD | ||
GLIS3 | 610192 | Diabetes mellitus, neonatal, with congenital hypothyroidism | AR |
GLUD1 | 138130 | Hyperinsulinism-hyperammonemia syndrome | AD |
GMPPA | 615495 | Alacrima, achalasia, and mental retardation syndrome | AR |
GNAS | 139320 | Pseudohypoparathyroidism Ic | AD |
Osseous heteroplasia, progressive | AD | ||
Pseudopseudohypoparathyroidism | AD | ||
Pseudohypoparathyroidism Ia | AD | ||
Pseudohypoparathyroidism Ib | AD | ||
Pituitary adenoma 3, multiple types, somatic | - | ||
ACTH-independent macronodular adrenal hyperplasia | SM | ||
McCune-Albright syndrome, somatic, mosaic | - | ||
GNE | 603824 | Nonaka myopathy | AR |
Sialuria | AD | ||
GPC3 | 300037 | Simpson-Golabi-Behmel syndrome, type 1 | XLR |
Wilms tumor, somatic | - | ||
GPD1 | 138420 | Hypertriglyceridemia, transient infantile | AR |
GPIHBP1 | 612757 | Hyperlipoproteinemia, type 1D | AR |
GYS1 | 138570 | Glycogen storage disease 0, muscle | AR |
GYS2 | 138571 | Glycogen storage disease 0, liver | AR |
H6PD | 138090 | Cortisone reductase deficiency 1 | AR |
HADH | 601609 | 3-hydroxyacyl-CoA dehydrogenase deficiency | AR |
Hyperinsulinemic hypoglycemia, familial, 4 | AR | ||
HEXA | 606869 | Tay-Sachs disease | AR |
[Hex A pseudodeficiency] | AR | ||
GM2-gangliosidosis, several forms | AR | ||
HMGCL | 613898 | HMG-CoA lyase deficiency | AR |
HMGCS2 | 600234 | HMG-CoA synthase-2 deficiency | AR |
HNF1A | 142410 | Diabetes mellitus, insulin-dependent | AR |
Diabetes mellitus, insulin-dependent, 20 | - | ||
MODY, type III | AD | ||
Diabetes mellitus, noninsulin-dependent, 2 | AD | ||
Hepatic adenoma, somatic | - | ||
Renal cell carcinoma | - | ||
HNF1B | 189907 | Renal cysts and diabetes syndrome | AD |
Diabetes mellitus, noninsulin-dependent | AD | ||
Renal cell carcinoma | - | ||
HNF4A | 600281 | Fanconi renotubular syndrome 4, with maturity-onset diabetes of the young | AD |
Diabetes mellitus, noninsulin-dependent | AD | ||
MODY, type I | AD | ||
HSD11B1 | 600713 | Cortisone reductase deficiency 2 | AD |
IER3IP1 | 609382 | Microcephaly, epilepsy, and diabetes syndrome | AR |
IFT172 | 607386 | Retinitis pigmentosa 71 | AR |
Bardet-Biedl syndrome 20 | AR | ||
Short-rib thoracic dysplasia 10 with or without polydactyly | AR | ||
IFT27 | 615870 | ?Bardet-Biedl syndrome 19 | AR |
IGF1R | 147370 | Insulin-like growth factor I, resistance to | AD, AR |
INPP5E | 613037 | Mental retardation, truncal obesity, retinal dystrophy, and micropenis | AR |
Joubert syndrome 1 | AR | ||
INS | 176730 | Diabetes mellitus, insulin-dependent, 2 | AD |
Maturity-onset diabetes of the young, type 10 | AD | ||
Hyperproinsulinemia | AD | ||
Diabetes mellitus, permanent neonatal 4 | AD, AR | ||
INSR | 147670 | Diabetes mellitus, insulin-resistant, with acanthosis nigricans | - |
Rabson-Mendenhall syndrome | AR | ||
Hyperinsulinemic hypoglycemia, familial, 5 | AD | ||
Leprechaunism | AR | ||
ITCH | 606409 | Autoimmune disease, multisystem, with facial dysmorphism | AR |
KCNJ11 | 600937 | Maturity-onset diabetes of the young, type 13 | AD |
Diabetes mellitus, transient neonatal 3 | AD | ||
Hyperinsulinemic hypoglycemia, familial, 2 | AD, AR | ||
Diabetes, permanent neonatal 2, with or without neurologic features | AD | ||
Diabetes mellitus, type 2, susceptibility to | AD | ||
KIDINS220 | 615759 | Ventriculomegaly and arthrogryposis | AR |
Spastic paraplegia, intellectual disability, nystagmus, and obesity | AD | ||
KIF7 | 611254 | Joubert syndrome 12 | AR |
?Hydrolethalus syndrome 2 | AR | ||
?Al-Gazali-Bakalinova syndrome | AR | ||
Acrocallosal syndrome | AR | ||
KLF11 | 603301 | Maturity-onset diabetes of the young, type VII | - |
KMT2C | 606833 | Kleefstra syndrome 2 | AD |
LAMP2 | 309060 | Danon disease | XLD |
LARGE1 | 603590 | Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 6 | AR |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6 | AR | ||
LAS1L | 300964 | Wilson-Turner syndrome | XLR |
LDHA | 150000 | Glycogen storage disease XI | AR |
LDLR | 606945 | LDL cholesterol level QTL2 | AD, AR |
Hypercholesterolemia, familial, 1 | AD, AR | ||
LDLRAP1 | 605747 | Hypercholesterolemia, familial, 4 | AR |
LEP | 164160 | Obesity, morbid, due to leptin deficiency | AR |
LEPR | 601007 | Obesity, morbid, due to leptin receptor deficiency | AR |
LIPA | 613497 | Wolman disease | AR |
Cholesteryl ester storage disease | AR | ||
LIPC | 151670 | [High density lipoprotein cholesterol level QTL 12] | - |
Hepatic lipase deficiency | AR | ||
Diabetes mellitus, noninsulin-dependent | AD | ||
LIPE | 151750 | Lipodystrophy, familial partial, type 6 | AR |
LMF1 | 611761 | Lipase deficiency, combined | AR |
LMNA | 150330 | Restrictive dermopathy 2 | - |
Malouf syndrome | AD | ||
Emery-Dreifuss muscular dystrophy 3, autosomal recessive | AR | ||
Emery-Dreifuss muscular dystrophy 2, autosomal dominant | AD | ||
Hutchinson-Gilford progeria | AD | ||
Muscular dystrophy, congenital | AD | ||
Restrictive dermopathy, lethal | AR | ||
Lipodystrophy, familial partial, type 2 | AD | ||
Charcot-Marie-Tooth disease, type 2B1 | AR | ||
Mandibuloacral dysplasia | AR | ||
Cardiomyopathy, dilated, 1A | AD | ||
Heart-hand syndrome, Slovenian type | AD | ||
LPL | 609708 | [High density lipoprotein cholesterol level QTL 11] | AR |
Combined hyperlipidemia, familial | AD | ||
Lipoprotein lipase deficiency | AR | ||
LZTFL1 | 606568 | Bardet-Biedl syndrome 17 | AR |
MAGEL2 | 605283 | Schaaf-Yang syndrome | AD |
MAN1B1 | 604346 | Rafiq syndrome | AR |
MC3R | 155540 | Obesity, severe, susceptibility to, BMIQ9 | - |
MC4R | 155541 | Obesity (BMIQ20) | AD, AR |
Obesity, resistance to (BMIQ20) | AD, AR | ||
MEGF8 | 604267 | Carpenter syndrome 2 | AR |
MGAT2 | 602616 | Congenital disorder of glycosylation, type IIa | AR |
MKKS | 604896 | McKusick-Kaufman syndrome | AR |
Bardet-Biedl syndrome 6 | AR | ||
MKRN3 | 603856 | Precocious puberty, central, 2 | AD |
MKS1 | 609883 | Bardet-Biedl syndrome 13 | AR |
Joubert syndrome 28 | AR | ||
Meckel syndrome 1 | AR | ||
MOGS | 601336 | Congenital disorder of glycosylation, type IIb | AR |
MPDU1 | 604041 | Congenital disorder of glycosylation, type If | AR |
MPI | 154550 | Congenital disorder of glycosylation, type Ib | AR |
MPV17 | 137960 | Charcot-Marie-Tooth disease, axonal, type 2EE | AR |
Mitochondrial DNA depletion syndrome 6 (hepatocerebral type) | AR | ||
MRAP2 | 615410 | ?Obesity, susceptibility to, BMIQ18 | AD |
MTNR1B | 600804 | Diabetes mellitus, type 2, susceptibility to | AD |
MTTP | 157147 | Metabolic syndrome, protection against | AD |
Abetalipoproteinemia | AR | ||
MYO5A | 160777 | Griscelli syndrome, type 1 | AR |
MYO7A | 276903 | Deafness, autosomal dominant 11 | AD |
Usher syndrome, type 1B | AR | ||
Deafness, autosomal recessive 2 | AR | ||
MYT1L | 613084 | Mental retardation, autosomal dominant 39 | AD |
NDN | 602117 | Prader-Willi syndrome | AD |
NEUROD1 | 601724 | Type 2 diabetes mellitus, susceptibility to | AD |
Maturity-onset diabetes of the young 6 | - | ||
NEUROG3 | 604882 | Diarrhea 4, malabsorptive, congenital | AR |
NGLY1 | 610661 | Congenital disorder of deglycosylation | AR |
NHLRC1 | - | Epilepsy, progressive myoclonic 2B (Lafora) | AR |
NPHP1 | 607100 | Joubert syndrome 4 | AR |
Nephronophthisis 1, juvenile | AR | ||
Senior-Loken syndrome-1 | AR | ||
NPHP3 | 608002 | Nephronophthisis 3 | AR |
Meckel syndrome 7 | AR | ||
Renal-hepatic-pancreatic dysplasia 1 | AR | ||
NR0B2 | 604630 | Obesity, mild, early-onset | AD, AR, MF |
NSD1 | 606681 | Sotos syndrome 1 | AD |
NTRK2 | 600456 | Developmental and epileptic encephalopathy 58 | AD |
Obesity, hyperphagia, and developmental delay | AD | ||
OFD1 | 300170 | Joubert syndrome 10 | XLR |
Simpson-Golabi-Behmel syndrome, type 2 | XLR | ||
?Retinitis pigmentosa 23 | XLR | ||
Orofaciodigital syndrome I | XLD | ||
OXCT1 | - | Succinyl CoA:3-oxoacid CoA transferase deficiency | AR |
PAX4 | 167413 | Maturity-onset diabetes of the young, type IX | - |
Diabetes mellitus, ketosis-prone, susceptibility to | AD, AR | ||
Diabetes mellitus, type 2 | AD | ||
PAX6 | 607108 | ?Coloboma, ocular | AD |
Aniridia | AD | ||
?Morning glory disc anomaly | AD | ||
Keratitis | AD | ||
Optic nerve hypoplasia | AD | ||
?Coloboma of optic nerve | AD | ||
Anterior segment dysgenesis 5, multiple subtypes | AD | ||
Cataract with late-onset corneal dystrophy | AD | ||
Foveal hypoplasia 1 | AD | ||
PC | 608786 | Pyruvate carboxylase deficiency | AR |
PCBD1 | 126090 | Hyperphenylalaninemia, BH4-deficient, D | AR |
PCK1 | 614168 | ?Phosphoenolpyruvate carboxykinase deficiency, cytosolic | AR |
PCNT | 605925 | Microcephalic osteodysplastic primordial dwarfism, type II | AR |
PCSK1 | 162150 | Obesity with impaired prohormone processing | AR |
Obesity, susceptibility to, BMIQ12 | - | ||
PCSK9 | 607786 | Hypercholesterolemia, familial, 3 | AD |
Low density lipoprotein cholesterol level QTL 1 | AD | ||
PDE11A | 604961 | Pigmented nodular adrenocortical disease, primary, 2 | AD |
PDE4D | 600129 | Acrodysostosis 2, with or without hormone resistance | AD |
PDX1 | 600733 | Pancreatic agenesis 1 | AR |
MODY, type IV | - | ||
Diabetes mellitus, type II, susceptibility to | AD | ||
PFKM | 610681 | Glycogen storage disease VII | AR |
PGAM2 | 612931 | Glycogen storage disease X | AR |
PGK1 | 311800 | Phosphoglycerate kinase 1 deficiency | XLR |
PGM1 | 171900 | Congenital disorder of glycosylation, type It | AR |
PHF6 | 300414 | Borjeson-Forssman-Lehmann syndrome | XLR |
PHIP | 612870 | Chung-Jansen syndrome | AD |
PHKA1 | 311870 | Muscle glycogenosis | XLR |
PHKA2 | 300798 | Glycogen storage disease, type IXa1 | XLR |
Glycogen storage disease, type IXa2 | XLR | ||
PHKB | 172490 | Phosphorylase kinase deficiency of liver and muscle, autosomal recessive | AR |
PHKG2 | 172471 | Glycogen storage disease IXc | AR |
PIK3R1 | 171833 | ?Agammaglobulinemia 7, autosomal recessive | AR |
Immunodeficiency 36 | AD | ||
SHORT syndrome | AD | ||
PMM2 | 601785 | Congenital disorder of glycosylation, type Ia | AR |
PNPLA6 | 603197 | Spastic paraplegia 39, autosomal recessive | AR |
Boucher-Neuhauser syndrome | AR | ||
Oliver-McFarlane syndrome | AR | ||
?Laurence-Moon syndrome | AR | ||
POLD1 | 174761 | Colorectal cancer, susceptibility to, 10 | AD |
Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome | AD | ||
POMC | 176830 | Obesity, adrenal insufficiency, and red hair due to POMC deficiency | AR |
Obesity, early-onset, susceptibility to | AD, AR, MF | ||
PPARG | - | Carotid intimal medial thickness 1 | - |
Obesity, severe | AD, AR, MF | ||
Lipodystrophy, familial partial, type 3 | AD | ||
Diabetes, type 2 | AD | ||
Insulin resistance, severe, digenic | AD | ||
PPP1R15B | 613257 | Microcephaly, short stature, and impaired glucose metabolism 2 | AR |
PRKAG2 | 602743 | Glycogen storage disease of heart, lethal congenital | AD |
Cardiomyopathy, hypertrophic 6 | AD | ||
Wolff-Parkinson-White syndrome | AD | ||
PRKAR1A | 188830 | Myxoma, intracardiac | AD |
Pigmented nodular adrenocortical disease, primary, 1 | AD | ||
Carney complex, type 1 | AD | ||
Acrodysostosis 1, with or without hormone resistance | AD | ||
PRMT7 | 610087 | Short stature, brachydactyly, intellectual developmental disability, and seizures | AR |
PROM1 | 604365 | Cone-rod dystrophy 12 | AD, AR |
Macular dystrophy, retinal, 2 | AD | ||
Retinitis pigmentosa 41 | AR | ||
Stargardt disease 4 | AD | ||
PRPH2 | 179605 | Retinitis pigmentosa 7 and digenic form | AD, AR, DD |
Retinitis punctata albescens | AD, AR | ||
Choroidal dystrophy, central areolar 2 | AD | ||
Macular dystrophy, patterned, 1 | AD | ||
Macular dystrophy, vitelliform, 3 | AD | ||
Leber congenital amaurosis 18 | AD, AR, DD | ||
PTEN | 601728 | Cowden syndrome 1 | AD |
Lhermitte-Duclos syndrome | AD | ||
Macrocephaly/autism syndrome | AD | ||
Glioma susceptibility 2 | - | ||
Meningioma | AD | ||
Prostate cancer, somatic | - | ||
PTF1A | 607194 | Pancreatic and cerebellar agenesis | AR |
Pancreatic agenesis 2 | AR | ||
PYGL | 613741 | Glycogen storage disease VI | AR |
PYGM | 608455 | McArdle disease | AR |
RAB23 | 606144 | Carpenter syndrome | AR |
RAI1 | 607642 | Smith-Magenis syndrome | AD, IC |
RBCK1 | 610924 | Polyglucosan body myopathy 1 with or without immunodeficiency | AR |
RDH5 | 601617 | Fundus albipunctatus | AD, AR |
RFT1 | 611908 | Congenital disorder of glycosylation, type In | AR |
RFX6 | 612659 | Mitchell-Riley syndrome | AR |
RHO | 180380 | Retinitis punctata albescens | AD, AR |
Retinitis pigmentosa 4, autosomal dominant or recessive | AD, AR | ||
Night blindness, congenital stationary, autosomal dominant 1 | - | ||
RLBP1 | 180090 | Newfoundland rod-cone dystrophy | - |
Fundus albipunctatus | AD, AR | ||
Retinitis punctata albescens | AD, AR | ||
Bothnia retinal dystrophy | AR | ||
RPGRIP1L | 610937 | Joubert syndrome 7 | AR |
?COACH syndrome 3 | AR | ||
Meckel syndrome 5 | AR | ||
RPS6KA3 | 300075 | Coffin-Lowry syndrome | XLD |
Mental retardation, X-linked 19 | XLD | ||
SDCCAG8 | 613524 | Bardet-Biedl syndrome 16 | AR |
Senior-Loken syndrome 7 | AR | ||
SETD2 | 612778 | Luscan-Lumish syndrome | AD |
Rabin-Pappas syndrome | - | ||
Intellectual developmental disorder, autosomal dominant 70 | - | ||
SLC16A1 | 600682 | Hyperinsulinemic hypoglycemia, familial, 7 | AD |
Erythrocyte lactate transporter defect | AD | ||
Monocarboxylate transporter 1 deficiency | AD, AR | ||
SLC19A2 | 603941 | Thiamine-responsive megaloblastic anemia syndrome | AR |
SLC29A3 | 612373 | Histiocytosis-lymphadenopathy plus syndrome | AR |
SLC2A2 | 138160 | Fanconi-Bickel syndrome | AR |
Diabetes mellitus, noninsulin-dependent | AD | ||
SLC35A1 | 605634 | Congenital disorder of glycosylation, type IIf | AR |
SLC35A2 | 314375 | Congenital disorder of glycosylation, type IIm | Somatic mosaicism, XLD |
SLC35C1 | 605881 | Congenital disorder of glycosylation, type IIc | AR |
SNRPN | 182279 | Prader-Willi syndrome | AD |
SPG11 | 610844 | Spastic paraplegia 11, autosomal recessive | AR |
Amyotrophic lateral sclerosis 5, juvenile | AR | ||
Charcot-Marie-Tooth disease, axonal, type 2X | AR | ||
SRD5A3 | 611715 | Congenital disorder of glycosylation, type Iq | AR |
Kahrizi syndrome | AR | ||
SSR4 | 300090 | Congenital disorder of glycosylation, type Iy | XLR |
STAT1 | 600555 | Immunodeficiency 31C, chronic mucocutaneous candidiasis, autosomal dominant | AD |
Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive | AR | ||
Immunodeficiency 31A, mycobacteriosis, autosomal dominant | AD | ||
STAT3 | 102582 | Hyper-IgE recurrent infection syndrome | AD |
Autoimmune disease, multisystem, infantile-onset, 1 | AD | ||
TBX3 | 601621 | Ulnar-mammary syndrome | AD |
THOC2 | 300395 | Mental retardation, X-linked 12/35 | XLR |
THRA | 190120 | Hypothyroidism, congenital, nongoitrous, 6 | AD |
TMEM165 | 614726 | Congenital disorder of glycosylation, type IIk | AR |
TMEM67 | 609884 | COACH syndrome 1 | AR |
?RHYNS syndrome | AR | ||
Meckel syndrome 3 | AR | ||
Joubert syndrome 6 | AR | ||
Bardet-Biedl syndrome 14, modifier of | AR | ||
Nephronophthisis 11 | AR | ||
TRAF3IP1 | 607380 | Senior-Loken syndrome 9 | AR |
TRAPPC9 | 611966 | Mental retardation, autosomal recessive 13 | AR |
TRIM32 | 602290 | Muscular dystrophy, limb-girdle, autosomal recessive 8 | AR |
?Bardet-Biedl syndrome 11 | AR | ||
TRMT10A | 616013 | Microcephaly, short stature, and impaired glucose metabolism 1 | AR |
TTC21B | 612014 | Short-rib thoracic dysplasia 4 with or without polydactyly | AR |
Nephronophthisis 12 | AD, AR | ||
TTC8 | - | Bardet-Biedl syndrome 8 | AR |
?Retinitis pigmentosa 51 | AR | ||
TUSC3 | 601385 | Mental retardation, autosomal recessive 7 | AR |
UCP2 | 601693 | Obesity, susceptibility to, BMIQ4 | - |
UCP3 | 602044 | Obesity, severe, and type II diabetes | AD, AR, MF |
VPS13B | 607817 | Cohen syndrome | AR |
WFS1 | 606201 | ?Cataract 41 | AD |
Wolfram-like syndrome, autosomal dominant | AD | ||
Wolfram syndrome 1 | AR | ||
Diabetes mellitus, noninsulin-dependent, association with | AD | ||
Deafness, autosomal dominant 6/14/38 | AD | ||
XRCC4 | 194363 | Short stature, microcephaly, and endocrine dysfunction | AR |
XYLT1 | - | Desbuquois dysplasia 2 | AR |
Pseudoxanthoma elasticum, modifier of severity of | AR | ||
ZBTB20 | 606025 | Primrose syndrome | AD |
ZFP57 | 612192 | Diabetes mellitus, transient neonatal 1 | AD |
ZMPSTE24 | 606480 | Restrictive dermopathy, lethal | AR |
Mandibuloacral dysplasia with type B lipodystrophy | AR | ||
ZNF711 | 314990 | Mental retardation, X-linked 97 | XL |
COMMON SYNDROMES AND DISORDERS COVERED
- Bardet-Biedl syndrome
- Congenital glycosylation disease
- Congenital hyperinsulinism
- Congenital hypothyroidism
- Diabetes insipidus
- Growth hormone deficiency
- Familial hypercholesterolemia
- Hypoglycemia
- Maturity onset diabetes of the young
- Neonatal diabetes
- Obesity
Pancreatitis panel
Our pancreatitis panel includes genes associated with chronic pancreatitis. It can also be used for differential diagnosis, as it includes genes associated with pancreatic cancer.
No. of genes: | 29 |
---|---|
TAT: | 25 business days |
Coverage: | ≥99.00% ≥20x |
Details: |
NGS including CNV analysis
Sanger sequencing: CFTR
|
Gene | OMIM (Gene) | Associated diseases (OMIM) | Inheritance |
---|---|---|---|
ABCB4 | 171060 | Gallbladder disease 1 | AD, AR |
Cholestasis, progressive familial intrahepatic 3 | AR | ||
Cholestasis, intrahepatic, of pregnancy, 3 | AD, AR | ||
APC | 611731 | Colorectal cancer, somatic | - |
Gastric cancer, somatic | - | ||
Gastric adenocarcinoma and proximal polyposis of the stomach | AD | ||
Desmoid disease, hereditary | AD | ||
Adenomatous polyposis coli | AD | ||
Gardner syndrome | AD | ||
Brain tumor-polyposis syndrome 2 | AD | ||
Hepatoblastoma, somatic | - | ||
APOA5 | 606368 | Hyperchylomicronemia, late-onset | AD |
Hypertriglyceridemia, susceptibility to | AD | ||
APOC2 | - | Hyperlipoproteinemia, type Ib | AR |
ATM | 607585 | Breast cancer, susceptibility to | AD, SM |
Ataxia-telangiectasia | AR | ||
BMPR1A | 601299 | Polyposis, juvenile intestinal | AD |
Juvenile polyposis syndrome, infantile form | AD | ||
Polyposis syndrome, hereditary mixed, 2 | - | ||
BRCA1 | 113705 | Breast-ovarian cancer, familial, 1 | AD, MF |
Pancreatic cancer, susceptibility to, 4 | - | ||
Fanconi anemia, complementation group S | AR | ||
BRCA2 | 600185 | Prostate cancer | AD, SM |
Breast-ovarian cancer, familial, 2 | AD | ||
Glioblastoma 3 | AR | ||
Wilms tumor | AD, SM | ||
Pancreatic cancer 2 | - | ||
Breast cancer, male, susceptibility to | AD, SM | ||
Fanconi anemia, complementation group D1 | AR | ||
Medulloblastoma | AD, AR, SM | ||
CASR | 601199 | Epilepsy idiopathic generalized, susceptibility to, 8 | - |
Hypocalcemia, autosomal dominant, with Bartter syndrome | AD | ||
Hypocalciuric hypercalcemia, type I | AD | ||
Hyperparathyroidism, neonatal | AD, AR | ||
Hypocalcemia, autosomal dominant | AD | ||
CDKN2A | 600160 | Melanoma and neural system tumor syndrome | AD |
Melanoma-pancreatic cancer syndrome | AD | ||
Melanoma, cutaneous malignant, 2 | AD | ||
CFTR | 602421 | Congenital bilateral absence of vas deferens | AR |
Pancreatitis, hereditary | AD | ||
Bronchiectasis with or without elevated sweat chloride 1, modifier of | AD | ||
Cystic fibrosis | AR | ||
CTRC | 601405 | Pancreatitis, chronic, susceptibility to | AD |
EPCAM | 185535 | Colorectal cancer, hereditary nonpolyposis, type 8 | AD |
Diarrhea 5, with tufting enteropathy, congenital | AR | ||
GPIHBP1 | 612757 | Hyperlipoproteinemia, type 1D | AR |
LPL | 609708 | [High density lipoprotein cholesterol level QTL 11] | AR |
Combined hyperlipidemia, familial | AD | ||
Lipoprotein lipase deficiency | AR | ||
MEN1 | 613733 | Multiple endocrine neoplasia 1 | AD |
MLH1 | 120436 | Mismatch repair cancer syndrome 1 | AR |
Muir-Torre syndrome | AD | ||
Colorectal cancer, hereditary nonpolyposis, type 2 | - | ||
MSH2 | 609309 | Muir-Torre syndrome | AD |
Colorectal cancer, hereditary nonpolyposis, type 1 | AD | ||
Mismatch repair cancer syndrome 2 | AR | ||
MSH6 | 600678 | Colorectal cancer, hereditary nonpolyposis, type 5 | AD |
Endometrial cancer, familial | AD, SM | ||
Mismatch repair cancer syndrome 3 | AR | ||
PALB2 | 610355 | Pancreatic cancer, susceptibility to, 3 | - |
Fanconi anemia, complementation group N | - | ||
Breast cancer, susceptibility to | AD, SM | ||
PMS2 | 600259 | Colorectal cancer, hereditary nonpolyposis, type 4 | - |
Mismatch repair cancer syndrome 4 | AR | ||
PRSS1 | 276000 | Pancreatitis, hereditary | AD |
SMAD4 | 600993 | Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome | AD |
Pancreatic cancer, somatic | - | ||
Myhre syndrome | AD | ||
Polyposis, juvenile intestinal | AD | ||
SPINK1 | 167790 | Tropical calcific pancreatitis | AD, AR |
Pancreatitis, hereditary | AD | ||
Fibrocalculous pancreatic diabetes, susceptibility to | AD, AR | ||
STK11 | 602216 | Peutz-Jeghers syndrome | AD |
Melanoma, malignant, somatic | - | ||
Testicular tumor, somatic | - | ||
Pancreatic cancer, somatic | - | ||
TP53 | 191170 | Hepatocellular carcinoma, somatic | - |
Bone marrow failure syndrome 5 | AD | ||
Basal cell carcinoma 7 | AD | ||
Nasopharyngeal carcinoma, somatic | - | ||
Choroid plexus papilloma | AD | ||
Glioma susceptibility 1 | AD, SM | ||
Pancreatic cancer, somatic | - | ||
Breast cancer, somatic | - | ||
Li-Fraumeni syndrome | AD | ||
Adrenocortical carcinoma, pediatric | AD | ||
Osteosarcoma | SM | ||
Colorectal cancer | AD, SM | ||
UBR1 | 605981 | Johanson-Blizzard syndrome | AR |
VHL | 608537 | Pheochromocytoma | AD |
von Hippel-Lindau syndrome | AD | ||
Renal cell carcinoma, somatic | - | ||
Erythrocytosis, familial, 2 | AR |
COMMON SYNDROMES AND DISORDERS COVERED
- Pancreatic cancer
- Pancreatitis
Congenital adrenal hyperplasia(CAH) panel
Our congenital adrenal hyperplasia (CAH) panel is designed for patients suspected of having CAH. CAH is a group of inherited disorders characterized by improper functioning of the adrenal glands, leading to abnormal production of steroid hormones, such as a cortisol or aldosterone. Our panel includes the analysis of the CYP21A2 gene, which codes for the enzyme 21-hydroxylase. More than 90.0% of CAH cases are caused by a deficiency of this enzyme.
No. of genes: | 12 |
---|---|
TAT: | 25 business days |
Coverage: | ≥99.00% ≥20x |
Details: |
NGS including CNV analysis
MLPA: CYP21A2
Sanger sequencing: CYP21A2
|
Gene | OMIM (Gene) | Associated diseases (OMIM) | Inheritance |
---|---|---|---|
ARMC5 | 615549 | ACTH-independent macronodular adrenal hyperplasia 2 | AD, SM |
CYP11A1 | 118485 | Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete | - |
CYP11B1 | 610613 | Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency | AR |
Aldosteronism, glucocorticoid-remediable | AD | ||
CYP11B2 | 124080 | Hypoaldosteronism, congenital, due to CMO II deficiency | AR |
Hypoaldosteronism, congenital, due to CMO I deficiency | AR | ||
CYP17A1 | 609300 | 17, 20-lyase deficiency, isolated | AR |
17-alpha-hydroxylase/17, 20-lyase deficiency | AR | ||
CYP21A2 | 613815 | Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency | AR |
Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency | AR | ||
HSD3B2 | 613890 | Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency | AR |
PDE11A | 604961 | Pigmented nodular adrenocortical disease, primary, 2 | AD |
PDE8B | 603390 | Striatal degeneration, autosomal dominant | AD |
Pigmented nodular adrenocortical disease, primary, 3 | - | ||
POR | 124015 | Disordered steroidogenesis due to cytochrome P450 oxidoreductase | - |
Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis | AR | ||
PRKAR1A | 188830 | Myxoma, intracardiac | AD |
Pigmented nodular adrenocortical disease, primary, 1 | AD | ||
Carney complex, type 1 | AD | ||
Acrodysostosis 1, with or without hormone resistance | AD | ||
STAR | 600617 | Lipoid adrenal hyperplasia | AR |
COMMON SYNDROMES AND DISORDERS COVERED
- Congenital adrenal hyperplasia